Jellagen Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 13

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 11

Jellagen General Information

Description

Developer of collagen products designed to address complex tissue engineering and regenerative medical needs. The company's products offer non-mammalian jellyfish collagen ranging from in-vitro to in-vivo applications, as well as a batch-to-batch consistency offering advantages to research and medical applications, enabling medicinal researchers to conduct in-house research and development and supporting the fabrication of new medical devices offering new approaches to wound management and tissue engineering.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Unit G6, Capital Business Park
  • Parkway, Saint Mellons
  • Cardiff CF3 2PY
  • Wales, United Kingdom
+44 0333
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Unit G6, Capital Business Park
  • Parkway, Saint Mellons
  • Cardiff CF3 2PY
  • Wales, United Kingdom
+44 0333

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Jellagen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC Completed Generating Revenue
9. Later Stage VC (Series A) 08-Dec-2022 Completed Generating Revenue
8. Angel (individual) 01-Mar-2022 Completed Generating Revenue
7. Early Stage VC 25-Jun-2020 Completed Generating Revenue
6. Early Stage VC 09-Apr-2019 Completed Generating Revenue
5. Secondary Transaction - Private 20-Feb-2019 Completed Generating Revenue
4. Early Stage VC (Series A) 27-Apr-2018 Completed Generating Revenue
3. Early Stage VC (Series A) 15-Dec-2016 Completed Startup
2. Early Stage VC 02-Sep-2015 $895K $895K Completed Startup
1. Grant 17-Aug-2015 $3.07M Completed Startup
To view Jellagen’s complete valuation and funding history, request access »

Jellagen Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
A Ordinary
B Preferred Ordinary
A Ordinary
Preferred Ordinary
Ordinary
A Ordinary
Preferred Ordinary
Preferred Ordinary 4,227 $0.011933 $112.93 $112.93 1x $112.93 2.92%
A Ordinary 1,849 $0.011933 $112.93 $112.93 1x $112.93 1.28%
To view Jellagen’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Jellagen Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of collagen products designed to address complex tissue engineering and regenerative medical needs. The compan
Pharmaceuticals
Cardiff, United Kingdom
13 As of 2026

Abano Terme, Italy
 

Trumbull, CT
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Jellagen Competitors (10)

One of Jellagen’s 10 competitors is Fidia Farmaceutici, a Formerly PE-Backed company based in Abano Terme, Italy.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Fidia Farmaceutici Formerly PE-Backed Abano Terme, Italy
ARVYS Proteins Corporation Trumbull, CT
ProSpec-Tany TechnoGene Corporation East Brunswick, NJ
Encoll Corporation Fremont, CA
SYMATESE Formerly PE-Backed Chaponost, France
You’re viewing 5 of 10 competitors. Get the full list »

Jellagen Patents

Jellagen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026038012-A1 Modified proteins and methods of manufacture thereof Pending 16-Aug-2024
GB-202405695-D0 Marine invertebrate collagen use Inactive 19-Apr-2024
WO-2025219725-A1 Marine invertebrate collagen use Pending 19-Apr-2024
JP-7867012-B2 Collagen extract for use as a pharmaceutical product Active 04-Mar-2021
JP-2024511299-A Collagen extract for use as medicine Active 04-Mar-2021 A61K35/614
To view Jellagen’s complete patent history, request access »

Jellagen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Jellagen Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cardiff Capital Region Infrastructure Minority
Thai Union Group Corporation Minority
Angels Invest Wales Angel Group Minority
MedCity Corporation Minority
Newable Partnership Growth/Expansion Minority
You’re viewing 5 of 11 investors. Get the full list »

Jellagen FAQs

  • When was Jellagen founded?

    Jellagen was founded in 2013.

  • Where is Jellagen headquartered?

    Jellagen is headquartered in Cardiff, United Kingdom.

  • What is the size of Jellagen?

    Jellagen has 13 total employees.

  • What industry is Jellagen in?

    Jellagen’s primary industry is Pharmaceuticals.

  • Is Jellagen a private or public company?

    Jellagen is a Private company.

  • What is Jellagen’s current revenue?

    The current revenue for Jellagen is .

  • How much funding has Jellagen raised over time?

    Jellagen has raised $24.3M.

  • Who are Jellagen’s investors?

    Cardiff Capital Region, Thai Union Group, Angels Invest Wales, MedCity, and Newable Partnership are 5 of 11 investors who have invested in Jellagen.

  • Who are Jellagen’s competitors?

    Fidia Farmaceutici, ARVYS Proteins, ProSpec-Tany TechnoGene, Encoll, and SYMATESE are some of the 10 competitors of Jellagen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process